The University of Southampton
University of Southampton Institutional Repository

Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: a review

Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: a review
Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: a review
Cognitive dysfunction in Alzheimer’s disease (AD) is caused by disturbances in neuronal circuits of the brain underpinned by synapse loss, neuronal dysfunction and neuronal death. Amyloid beta and tau protein cause these pathological changes and enhance neuroinflammation, which in turn modifies disease progression and severity. Vagal nerve stimulation (VNS), via activation of the locus coeruleus (LC), results in the release of catecholamines in the hippocampus and neocortex, which can enhance synaptic plasticity and reduce inflammatory signalling. Vagal nerve stimulation has shown promise to enhance cognitive ability in animal models. Research in rodents has shown that VNS can have positive effects on basal synaptic function and synaptic plasticity, tune inflammatory signalling, and limit the accumulation of amyloid plaques. Research in humans with invasive and non-invasive VNS devices has shown promise for the modulation of cognition. However, the direct stimulation of the vagus nerve afforded with the invasive procedure carries surgical risks. In contrast, non-invasive VNS has the potential to be a broadly available therapy to manage cognitive symptoms in early AD, however, the magnitude and specificity of its effects remains to be elucidated, and the non-inferiority of the effects of non-invasive VNS as compared with invasive VNS still needs to be established. Ongoing clinical trials with healthy individuals and patients with early AD will provide valuable information to clarify the potential benefits of non-invasive VNS in cognition and AD. Whether invasive or non-invasive VNS can produce a significant improvement on memory function and whether its effects can modify the progression of AD will require further investigation.
Alzheimer, MCI, memory, noradrenaline, norepinepherine, plasticity, vagal, vagus
1662-5161
Vargas-Caballero, Mariana
de2178ac-77fd-4748-9fe5-109ab8ad93e1
Warming, Hannah
52e41d3f-0cf4-440f-b0c9-cec47ed3b23a
Walker, Robert
9368ac2d-f1e9-4bd9-a4b4-4a161c4aa140
Holmes, Clive
ada5abf3-8459-4cf7-be40-3f4e9391cc96
Cruickshank, Garth
f7656619-ab1d-4cea-be4e-f6bc097736d2
Patel, Bipin
a1ba298c-2f06-4b54-86ee-a7ec5f130708
Vargas-Caballero, Mariana
de2178ac-77fd-4748-9fe5-109ab8ad93e1
Warming, Hannah
52e41d3f-0cf4-440f-b0c9-cec47ed3b23a
Walker, Robert
9368ac2d-f1e9-4bd9-a4b4-4a161c4aa140
Holmes, Clive
ada5abf3-8459-4cf7-be40-3f4e9391cc96
Cruickshank, Garth
f7656619-ab1d-4cea-be4e-f6bc097736d2
Patel, Bipin
a1ba298c-2f06-4b54-86ee-a7ec5f130708

Vargas-Caballero, Mariana, Warming, Hannah, Walker, Robert, Holmes, Clive, Cruickshank, Garth and Patel, Bipin (2022) Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: a review. Frontiers in Human Neuroscience, 16, [866434]. (doi:10.3389/fnhum.2022.866434).

Record type: Review

Abstract

Cognitive dysfunction in Alzheimer’s disease (AD) is caused by disturbances in neuronal circuits of the brain underpinned by synapse loss, neuronal dysfunction and neuronal death. Amyloid beta and tau protein cause these pathological changes and enhance neuroinflammation, which in turn modifies disease progression and severity. Vagal nerve stimulation (VNS), via activation of the locus coeruleus (LC), results in the release of catecholamines in the hippocampus and neocortex, which can enhance synaptic plasticity and reduce inflammatory signalling. Vagal nerve stimulation has shown promise to enhance cognitive ability in animal models. Research in rodents has shown that VNS can have positive effects on basal synaptic function and synaptic plasticity, tune inflammatory signalling, and limit the accumulation of amyloid plaques. Research in humans with invasive and non-invasive VNS devices has shown promise for the modulation of cognition. However, the direct stimulation of the vagus nerve afforded with the invasive procedure carries surgical risks. In contrast, non-invasive VNS has the potential to be a broadly available therapy to manage cognitive symptoms in early AD, however, the magnitude and specificity of its effects remains to be elucidated, and the non-inferiority of the effects of non-invasive VNS as compared with invasive VNS still needs to be established. Ongoing clinical trials with healthy individuals and patients with early AD will provide valuable information to clarify the potential benefits of non-invasive VNS in cognition and AD. Whether invasive or non-invasive VNS can produce a significant improvement on memory function and whether its effects can modify the progression of AD will require further investigation.

Text
fnhum-16-866434 - Version of Record
Available under License Creative Commons Attribution.
Download (585kB)

More information

Accepted/In Press date: 6 April 2022
e-pub ahead of print date: 29 April 2022
Published date: 29 April 2022
Additional Information: Funding Information: HW is funded by the Gerald Kerkut Trust and the Institute for Life Sciences, University of Southampton. Publisher Copyright: Copyright © 2022 Vargas-Caballero, Warming, Walker, Holmes, Cruickshank and Patel.
Keywords: Alzheimer, MCI, memory, noradrenaline, norepinepherine, plasticity, vagal, vagus

Identifiers

Local EPrints ID: 471403
URI: http://eprints.soton.ac.uk/id/eprint/471403
ISSN: 1662-5161
PURE UUID: 332b4303-12aa-4979-83da-58807b7af18d
ORCID for Mariana Vargas-Caballero: ORCID iD orcid.org/0000-0003-2326-4001
ORCID for Robert Walker: ORCID iD orcid.org/0000-0002-9031-7671
ORCID for Clive Holmes: ORCID iD orcid.org/0000-0003-1999-6912

Catalogue record

Date deposited: 07 Nov 2022 17:32
Last modified: 17 Mar 2024 03:53

Export record

Altmetrics

Contributors

Author: Hannah Warming
Author: Robert Walker ORCID iD
Author: Clive Holmes ORCID iD
Author: Garth Cruickshank
Author: Bipin Patel

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×